Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens.
about
Expression and extracellular release of a functional anti-trypanosome Nanobody® in Sodalis glossinidius, a bacterial symbiont of the tsetse flyNanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applicationsDescription of a nanobody-based competitive immunoassay to detect tsetse fly exposureSingle domain antibodies: promising experimental and therapeutic tools in infection and immunityAffinity is an important determinant of the anti-trypanosome activity of nanobodiesFlow cytometry-based methods for assessing soluble scFv activities and detecting antigens in solution.Monitoring biodegradative enzymes with nanobodies raised in Camelus dromedarius with mixtures of catabolic proteins.Generation of a nanobody targeting the paraflagellar rod protein of trypanosomesIsolation and optimization of camelid single-domain antibodies: Dirk Saerens' work on nanobodies.Generation of VHH antibodies against the Arabidopsis thaliana seed storage proteins.Single-domain antibodies and their utility.Characterization of camel nanobodies specific for superfolder GFP fusion proteins.An Anti-proteome Nanobody Library Approach Yields a Specific Immunoassay for Trypanosoma congolense Diagnosis Targeting Glycosomal Aldolase.Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.Antibody technology in proteomics.African trypanosomiasis and antibodies: implications for vaccination, therapy and diagnosis.Emerging trends in the diagnosis of human African Trypanosomiasis.Nanobodies®: proficient tools in diagnostics.Biotechnological applications of recombinant single-domain antibody fragments.Nanobodies as novel agents for disease diagnosis and therapy.Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier.Antibody Fragments as Probe in Biosensor Development.Development of oligoclonal nanobodies for targeting the tumor-associated glycoprotein 72 antigen.Nanobodies As Tools to Understand, Diagnose, and Treat African Trypanosomiasis.Dual beneficial effect of interloop disulfide bond for single domain antibody fragments.Chronic Trypanosoma congolense infections in mice cause a sustained disruption of the B-cell homeostasis in the bone marrow and spleen.Single Domain Antibodies as New Biomarker Detectors.
P2860
Q21246029-570AF2D6-AF2F-4502-91BF-8C2ACDD2BE01Q26738678-0731A832-F2D3-4464-900F-D8496B5218EDQ27304633-252E84D3-F35A-46A5-9308-9FDFD94409D4Q28248678-1AA32A4D-A38F-4D63-BC3B-D21B506EB1BEQ28485195-486ADDAA-23FA-4C33-8726-F1F951BDA6E3Q30938677-CC252E72-DB9C-41A1-8631-D71216B8A871Q33789505-FEFB8319-9442-448A-BFF6-E572EEEEF368Q34796514-E412D150-EB8F-432E-B9AB-963A197607F9Q34878849-78177017-F123-4FD5-96E5-51E8C5254052Q34959812-076D4236-2440-4B7A-916C-26E0E0C89F44Q35089545-0D41A2DF-CE8D-41E4-A7AC-F1E686A3C264Q35217452-52FB1B42-84B6-4E7C-89A3-CA0E9234BA58Q35911914-DA49811D-AC74-4957-9AB9-27F0D847979FQ36023082-DE543EB3-D883-4109-BB50-4A6EADE4A0CAQ37202448-0A1DF965-C5DF-4097-AD27-AF1AFCAA6D22Q37613678-4A142682-EBAD-4CDA-A6EE-522E8B35578CQ37728108-28387810-D668-436C-8F37-36F9D52B9D5EQ37789032-B7F1F5EE-B252-4BD8-84FD-D4C24B5376E6Q37887077-05A15D41-5E47-45C5-9D4A-14C4C2F1C092Q38160835-7CCFEBFA-561E-4041-A83A-064CF1FCC328Q38929360-9D860673-83CB-4F23-9ABA-C149DA2374F1Q39016494-3103C4E9-6D4F-4DA2-9BD5-C434610E226EQ39270763-038D734F-D4D7-4A50-A371-C1C6A5F9EFABQ39437960-15E0A702-3B24-431E-B9F7-07F0B1C043A5Q41347803-A050A548-B236-46D6-8501-686D967FED14Q46891128-66E3E8DF-B2DC-495B-A85F-CC3168E11137Q47099886-AE09523C-0B21-4FCB-980D-2FB6B0A411E9
P2860
Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Parallel selection of multiple ...... t access to purified antigens.
@ast
Parallel selection of multiple ...... t access to purified antigens.
@en
type
label
Parallel selection of multiple ...... t access to purified antigens.
@ast
Parallel selection of multiple ...... t access to purified antigens.
@en
prefLabel
Parallel selection of multiple ...... t access to purified antigens.
@ast
Parallel selection of multiple ...... t access to purified antigens.
@en
P2093
P50
P1476
Parallel selection of multiple ...... t access to purified antigens.
@en
P2093
Giang Thanh Nguyen Thi
Katja Conrath
Toya Nath Baral
Ulrich Wernery
P304
P356
10.1016/J.JIM.2007.10.005
P577
2007-10-31T00:00:00Z